Howie and Harlan are joined by Zhenqiu Lin, senior director of analytics at Yale’s Center for Outcomes Research and Evaluation, to discuss how quality measures can make care more consistent and effective and improve outcomes for patients. Howie provides an update on research on repetitive head trauma among young football players; Harlan reports on new findings about the benefits of semaglutide for people with heart disease.

Links:

“Neuropathologic and Clinical Findings in Young Contact Sport Athletes Exposed to Repetitive Head Impacts”

American Academy Of Pediatrics: “Tackling in Youth Football”

“National Use and Effectiveness of β-Blockers for the Treatment of Elderly Patients After Acute Myocardial Infarction”

“Twenty-Year Trends in Outcomes for Older Adults With Acute Myocardial Infarction in the United States”

“Quality Measure Public Reporting Is Associated with Improved Outcomes Following Hip and Knee Replacement”

“Novo Nordisk A/S: Semaglutide 2.4 mg reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial”

“Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity”

Learn more about the MBA for Executives program at Yale SOM.

Email Howie and Harlan comments or questions.